State Ledger
Company profile

Stoke Therapeutics, Inc. CIK 1623526

Ticker
STOK (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bedford, MA 01730
Fiscal year end
2025 (FY)
Market Data
Close
$24.14
Change
-$0.61
Change %
-2.45%
Volume
19,212

STOK · trading date Oct 12, 2026 · previous close $24.74 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$184.42M
Net income
-$6.89M
Total assets
$418.43M
Total liabilities
$65.98M
Stockholders' equity
$352.46M
Cash & equivalents
$84.22M
Operating income
-$20.59M
Operating cash flow
$45.59M
Capital expenditures
$670.0K

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-11.2%
Net margin
-3.7%
Free cash flow
$44.92M
Free cash flow margin
24.4%
Liabilities / assets
15.8%
Equity / assets
84.2%
CapEx / revenue
0.4%
Operating cash flow / net income
-6.62×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $184.42M -$6.89M $418.43M $65.98M $352.46M
2024 $36.56M -$88.98M $271.56M $42.53M $229.02M
2023 $8.78M -$104.70M $228.34M $68.78M $159.57M
2022 $12.41M -$101.07M $256.07M $71.22M $184.85M
2021 — -$85.81M $238.87M $21.09M $217.78M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-03
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bedford, MA 01730
45 WIGGINS AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies